Home > Financial Ratios > ASPIRA PATHLAB & DIAGNOSTICS

ASPIRA PATHLAB & DIAGNOSTICS
Price to Cash Earnings (PCE)

    Back to All Ratios
COMMUNITY POLL
for ASPIRA PATHLAB & DIAGNOSTICS
Please provide your vote to see the results

ASPIRA PATHLAB & DIAGNOSTICS Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2025Mar2024
   PCE(x) 24.95-28.15

What is the latest Price to Cash Earnings (PCE) ratio of ASPIRA PATHLAB & DIAGNOSTICS ?

The latest Price to Cash Earnings (PCE) ratio of ASPIRA PATHLAB & DIAGNOSTICS is 24.95 based on Mar2025 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202524.95
Mar2024-28.15

How is Price to Cash Earnings (PCE) of ASPIRA PATHLAB & DIAGNOSTICS Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 24.95
Positive
Mar2024 -28.15 -

Other Financial Ratios of ASPIRA PATHLAB & DIAGNOSTICS


Compare Price to Cash Earnings (PCE) ratio of peers of ASPIRA PATHLAB & DIAGNOSTICS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ASPIRA PATHLAB & DIAGNOSTICS ₹95.9 Cr 3.2% -23.7% 66.9% Stock Analytics
APOLLO HOSPITALS ENTERPRISE ₹128,114.0 Cr 0.1% 5.9% 22.7% Stock Analytics
MAX HEALTHCARE INSTITUTE ₹107,245.0 Cr 0.9% 1% -10.6% Stock Analytics
FORTIS HEALTHCARE ₹71,860.7 Cr -1.9% -0.7% 24.6% Stock Analytics
ASTER DM HEALTHCARE ₹71,006.4 Cr 0.2% 3.4% 35.3% Stock Analytics
NARAYANA HRUDAYALAYA ₹41,404.5 Cr 0.8% 8.5% 1.1% Stock Analytics


ASPIRA PATHLAB & DIAGNOSTICS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ASPIRA PATHLAB & DIAGNOSTICS

3.2%

-23.7%

66.9%

SENSEX

0.1%

0.7%

-6.6%


You may also like the below Video Courses